[1] 杨丽, 金鑫, 余福勋, 等.呼吸道合胞病毒感染A549细胞后对Ⅰ型干扰素抗病毒免疫应答的影响[J].微生物学免疫学进展, 2021, 49(6): 8-12.
Yang L,Jin X,Yu FX,et al.Effect of respiratory syncytial virus infection on type Ⅰ interferon response in A549 cells[J].Progress in Microbiology and Immunology,2021,49(6):8-12.(in Chinese)
[2] Li Y, Johnson EK, Shi T, et al.National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: A modelling study[J].Lancet Respir Med, 2021, 9(2): 175-185.
[3] Chunxi L, Haiyue L, Yanxia L, et al.The gut microbiota and respiratory diseases: New evidence[J].J Immunol Res, 2020, 2020: 2340670.
[4] Lo BC, Chen GY, Nunez G, et al.Gut microbiota and systemic immunity in health and disease[J].Int Immunol, 2021, 33(4): 197-209.
[5] Zhu W, Wu Y, Liu H, et al.Gut-lung axis: Microbial crosstalk in rediatric respiratory tract infections[J].Front Immunol, 2021, 12: 741233.
[6] Pabst O, Slack E.IgA and the intestinal microbiota: The importance of being specific[J].Mucosal Immunol, 2020, 13(1): 12-21.
[7] Chen Y, Xu J, Chen Y.Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders[J].Nutrients, 2021, 13(6):2099.
[8] Lavelle A, Sokol H.Gut microbiota-derived metabolites as key actors in inflammatory bowel disease[J].Nat Rev Gastroenterol Hepatol, 2020, 17(4): 223-237.
[9] 时晨,林丽丽,谢彤,等.基于“肺-肠”轴探讨肺、肠微生态对肺部疾病的影响[J].南京中医药大学学报, 2020, 36(2): 168-173.
Shi C,Lin LL,Xie T,et al.The role of the lung-gut axis and the lung and gut microorganism in pulmonary disease[J].J Nanjing Univ Tradit Chin Med,2020,36(2):168-173.(in Chinese)
[10] Jang JY, Kim S, Kwon MS, et al.Rotavirus-mediated alteration of gut microbiota and its correlation with physiological characteristics in neonatal calves[J].J Microbiol, 2019, 57(2): 113-121.
[11] Hanada S, Pirzadeh M, Carver KY, et al.Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia[J].Front Immunol, 2018, 9: 2640.
[12] Groves HT, Cuthbertson L, James P, et al.Respiratory disease following viral lung infection alters the murine gut microbiota[J].Front Immunol, 2018, 9: 182.
[13] Deriu E, Boxx GM, He X, et al.Influenza virus affects intestinal microbiota and secondary salmonella infection in the gut through type Ⅰ interferons[J].PLoS Pathog, 2016, 12(5): e1005572.
[14] Wang J, Li F, Wei H, et al.Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation[J].J Exp Med, 2014, 211(12): 2397-2410.
[15] Groves HT, Higham SL, Moffatt MF, et al.Respiratory viral infection alters the gut microbiota by inducing inappetence[J].mBio, 2019.doi:10.1101/666354
[16] Martin-Gallausiaux C, Marinelli L, Blottiere HM, et al.SCFA: Mechanisms and functional importance in the gut[J].Proc Nutr Soc, 2021, 80(1): 37-49.
[17] Machado MG, Sencio V, Trottein F.Short-chain fatty acids as a potential treatment for infections: A closer look at the lungs[J].Infect Immun, 2021, 89(9): e0018821.
[18] Trompette A, Gollwitzer ES, Pattaroni C, et al.Dietary fiber confers protection against flu by shaping Ly6c(-) patrolling monocyte hematopoiesis and CD8(+) T cell metabolism[J].Immunity, 2018, 48(5): 992-1005.
[19] Antunes KH, Fachi JL, De Paula R, et al.Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response[J].Nat Commun, 2019, 10(1): 3273.
[20] Ferolla FM, Hijano DR, Acosta PL, et al.Macronutrients during pregnancy and life-threatening respiratory syncytial virus infections in children[J].Am J Respir Crit Care Med, 2013, 187(9): 983-990.
[21] Steed AL, Christophi GP, Kaiko GE, et al.The microbial metabolite desaminotyrosine protects from influenza through type Ⅰ interferon[J].Science, 2017, 357(6350): 498-502.
[22] Rooks MG, Garrett WS.Gut microbiota, metabolites and host immunity[J].Nat Rev Immunol, 2016, 16(6): 341-352.
[23] Clarke TB.Early innate immunity to bacterial infection in the lung is regulated systemically by the commensal microbiota via nod-like receptor ligands[J].Infect Immun, 2014, 82(11): 4596-4606.
[24] Ichinohe T, Pang IK, Kumamoto Y, et al.Microbiota regulates immune defense against respiratory tract influenza: A virus infection[J].Proc Natl Acad Sci U S A, 2011, 108(13): 5354-5359.
[25] Van Winkle JA, Peterson ST, Kennedy EA, et al.Homeostatic interferon-lambda response to bacterial microbiota stimulates preemptive antiviral defense within discrete pockets of intestinal epithelium[J].Elife, 2022, 11:e74072.
[26] Wirusanti NI, Baldridge MT, Harris VC.Microbiota regulation of viral infections through interferon signaling[J].Trends Microbiol, 2022,5:S0966-842X(22)00007-5.
[27] Brown DG,Soto R,Yandamuri S,et al.The microbiota protects from viral-induced neurologic damage through microglia-intrinsic TLR signaling[J].Elife, 2019, 8:e47117.
[28] Zhang Q, Hu J, Feng JW, et al.Influenza infection elicits an expansion of gut population of endogenous bifidobacterium animalis which protects mice against infection[J].Genome Biol, 2020, 21(1): 99.
[29] Ranucci G, Buccigrossi V, de Freitas MB, et al.Early-life intestine microbiota and lung health in children[J].J Immunol Res, 2017, 2017: 8450496.
[30] Van Houten CB, Cohen A, Engelhard D, et al.Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment)[J].Eur J Clin Microbiol Infect Dis, 2019, 38(3): 505-514.
[31] Ferrer M, Martins Dos Santos VA, Ott SJ, et al.Gut microbiota disturbance during antibiotic therapy: A multi-omic approach[J].Gut Microbes, 2014, 5(1): 64-70.
[32] Bradley KC, Finsterbusch K, Schnepf D, et al.Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection[J].Cell Rep, 2019, 28(1): 245-256 e244.
[33] Schuijt TJ, Lankelma JM, Scicluna BP, et al.The gut microbiota plays a protective role in the host defence against pneumococcal pneumonia[J].Gut, 2016, 65(4): 575-583.
[34] Oh JZ, Ravindran R, Chassaing B, et al.TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination[J].Immunity, 2014, 41(3): 478-492.
[35] Yang M, Yang Y, He Q, et al.Intestinal microbiota-A promising target for antiviral therapy?[J].Front Immunol, 2021, 12: 676232.
[36] Jounai K, Sugimura T, Ohshio K, et al.Oral administration of Lactococcus lactis subsp.lactis JCM5805 enhances lung immune response resulting in protection from murine parainfluenza virus infection[J].PLoS One, 2015, 10(3): e0119055.
[37] Mahooti M, Abdolalipour E, Salehzadeh A, et al.Immunomodulatory and prophylactic effects of bifidobacterium bifidum probiotic strain on influenza infection in mice[J].World J Microbiol Biotechnol, 2019, 35(6):91.
[38] Ji JJ, Sun QM, Nie DY, et al.Probiotics protect against RSV infection by modulating the microbiota-alveolar-macrophage axis[J].Acta Pharmacol Sin, 2021, 42(10): 1630-1641.
[39] Maldonado Galdeano C, Cazorla SI, Lemme Dumit JM, et al.Beneficial effects of probiotic consumption on the immune system[J].Ann Nutr Metab, 2019, 74(2): 115-124.
[40] Sarkar A, Harty S, Moeller AH, et al.The gut microbiome as a biomarker of differential susceptibility to SARS-CoV-2[J].Trends Mol Med, 2021, 27(12): 1115-1134.